Figure GPS-15Lifetime prevalence of amphetamine use among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Notes:

Data are from the most recent national surveys available in each country (see epidemiological tables on population surveys, EMCDDA statistical bulletin).

The age range is from between 15 and 18 to between 59 and 64. Variations in age ranges may slightly influence disparities between countries.

Belgium: 2001 15-64 y. n=7347; 15-34 y. n=2758; 15-24 y. n=1152

Czech Republic: 2002 18-64 y. n=2526; 18-34 y. n=1002; 18-24 y. n=389

Denmark: 2000 16-64 y. n=11825; 16-34 y. n=4141; 16-24 y. n=1754

Germany: 2003 18-59 y. n=8061; 18-34 y. n=3775; 18-24 y. n=1891

Greece: 2004 15-64 y. n=4351; 15-34 y. n=2620; 15-24 y. n=1785

Spain: 2001 15-64 y. n=14113; 15-34 y. n=6915; 15-24 y. n=3368

France: 2002 15-64 y. n=1744; 15-34 y. n=724; 15-24 y. n=345

Ireland: 2002/03 15-64 y. n=4925; 15-34 y. n=; 15-24 y. n=

Italy: 2003 15-54 y. n=; 15-34 y. n=5231; 15-24 y. n=2112

Latvia: 2003 15-64 y. n=; 15-34 y. n=; 15-24 y. n=

Hungary: 2003 18-54 y. n=; 18-34 y. n=2319; 15-24 y. n=943

Netherlands 2000/01 15-64 y. n=14045; 15-34 y. n=6687; 15-24 y. n=

Poland: 2002 16+ y. n=3148; 16-34 y. n=; 16-24 y. n=

Portugal: 2001 15-64 y. n=14184; 15-34 y. n=6406; 15-24 y. n=3099

Slovakia: 2002 18-64 y. n=1405; 18-34 y. n=; 18-24 y. n=

Finland: 2002 15-64 y. n=2377; 15-34 y. n=1240; 15-24 y. n=614

UK (E&W): 2003/04 16-59 y. n=24422; 16-34 y. n=8590; 16-24 y. n=5429

Norway: 1999 15-64 y. n=1803; 15-34 y. n=794; 15-24 y. n=

Sources:

Reitox national reports 2004, taken from population surveys reports or scientific articles. See also standard epidemiological tables in EMCDDA statistical bulletin

Data filter | gpsfig15-en.xml